(CIDRAP News) Recent reports from Indonesian health officials tie the high fatality rate in human H5N1 influenza cases there to the difficulty of diagnosing the disease, late treatment with antiviral drugs, and a shortage of well-equipped hospitals.
(CIDRAP News) In a recent medical journal article, Indonesian officials detailed the rationale for their refusal to share H5N1 influenza virus samples with the World Health Organization (WHO), asserting that it was in part a response to violations of the WHO's own guidelines by scientists and laboratories.
(CIDRAP News) Government officials in Hong Kong, in an effort to stem to spread of the H5N1 avian influenza virus, recently followed through with their proposal to ban live poultry from overnight stays in market stalls and retail outlets.
(CIDRAP News) A pharmaceutical company is reporting good results in the first clinical trial of an H5N1 avian influenza vaccine that uses a whole, killed H5N1 virus grown in cell culturea combination of techniques that entails some risk but may boost immune response and shorten production time.
(CIDRAP News) A US Department of Health and Human Services (HHS) official today shared wrap-up perspectives on HHS Secretary Mike Leavitt's recent trip to Southeast Asia, which included discussions on virus-sharing and restrictions on the US Navy laboratory in Indonesia, updates on avian influenza collaborations, and talks on import safety.
(CIDRAP News) – US Health and Human Services (HHS) Secretary Mike Leavitt, in Vietnam today on the second leg of a 10-daytour of Southeast Asia, revealed new details on his blog today about his talks with Indonesian officials on two controversial issues: the country's refusal to freely share H5N1 virus samples and the status of the US Navy's medical laboratory unit, NAMRU-2.
(CIDRAP News) A World Health Organization (WHO) working group will meet in Geneva over the next 4 days to try to solve an impasse over how countries share their H5N1 avian influenza virus samples, a disagreement that pits developing countries' demand for affordable vaccines against the global need to monitor virus changes and develop pandemic vaccines.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.